Radio Cadena Agramonte emisiora de Camagüey
Havana, Jun 21st. - Cuba and the European Union (EU) will work together on the Biotec-Cuba biotechnology program, aimed at enhancing the research, production, regulation and regional trade exchange of biopharmaceuticals.
With EU funding and the collaboration of national and international agencies, the program seeks to raise scientific standards and improve access to innovative therapies and medicines for the Cuban population and the Latin American and Caribbean region, reports Prensa Latina.
The Biotec-Cuba program has funding of more than eight million euros and articulates efforts between the EU, the Ministry of Public Health, BioCubaFarma and the University of Havana.
In addition, the Centre for the State Control of Medicines, Medical Equipment and Devices, the Pan American Health Organization and the United Nations Development Programme participates.
The Biotec-Cuba initiative supports two pillars for the development of biotechnology: the first focuses on the promotion of existing research, development and innovation capacities (R&D&i) of the biotechnology and pharmaceutical industry.
With this project, it is planned to contribute to the promotion of Cuba's capacities in the production of drugs essential for clinical trials aimed at the development of innovative therapies, with the strengthening of the Industrial Biotechnological CIGB-Mariel S.A. (Granma Digital Newspaper) (Photo: Internet taken)
